Transl Neurodegener

DOPA-decarboxylase is elevated in CSF, but not plasma, in prodromal and de novo Parkinson's disease.

Appleton E, Khosousi S, Ta M, ..., Iwaki H, Svenningsson P

Transl Neurodegener 13 (1) 31 [2024-06-11; online 2024-06-11]

Affinity Proteomics Stockholm [Service]

Large-scale proximity extension assay reveals CSF midkine and DOPA decarboxylase as supportive diagnostic biomarkers for Parkinson's disease.

Paslawski W, Khosousi S, Hertz E, ..., Boxer A, Svenningsson P

Transl Neurodegener 12 (1) 42 [2023-09-04; online 2023-09-04]

Affinity Proteomics Stockholm [Service]

Advances in the development of new biomarkers for Alzheimer's disease.

Klyucherev TO, Olszewski P, Shalimova AA, ..., Syvänen S, Schiöth HB

Transl Neurodegener 11 (1) 25 [2022-04-21; online 2022-04-21]

Affinity Proteomics Uppsala [Service]

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.

Remnestål J, Öijerstedt L, Ullgren A, ..., Graff C, Nilsson P

Transl Neurodegener 9 (1) 27 [2020-06-23; online 2020-06-23]

Bioinformatics Support for Computational Resources [Service] NGI Stockholm (Genomics Applications) [Service] NGI Stockholm (Genomics Production) [Service] National Genomics Infrastructure [Service]